Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Final 2061
Stack #4731167
| Question | Answer |
|---|---|
| The primary goal of this standard setter is to monitor the burden of disease and plan effective prevention and control programs: | CDC NPCR |
| NCI, ACoS, CoC, the American Cancer Society and the American Association of Cancer Institute met to discuss how to assist and create a standardized population-based cancer registry data. This created what is now known as: | NAACCR |
| A tool created to focus on specific data elements to extract information automatically from pathology reports and other clinical documents is called: | Natural Language Processing |
| Which of the following serves as a research resource to NCI, providing for the conduct of studies that address issues dealing with cancer prevention and control? | SEER |
| Who is responsible for developing and publishing AJCCs staging standards? | multidisciplinary professional team |
| The first accreditation program focused on specialty care for a site-specific disease is: | Napbc |
| The NAACCR committee that prepares central registries to adapt rapidly and successfully to changing developments in cancer surveillance is the: | Standardization and Registry Development Steering Committee |
| The CoC's initial work focused on establishing : | Consistent diagnostic and cancer treatment through cancer clinics |
| In the US, the following is a nationally reportable chronic disease | cancer |
| Many states began to collect cancer incidence data on a state wide basis around which time period? | Late 1970s early 1980s |
| The standard setter that develops and promotes uniform data standards for cancer registration and oversees the Uniform Data Standards Committee is : | NAACCR |
| Which group is strategically aligned with the Alliance for Clinical Trials in Oncology and funded by the PCORI(patient centered outcomes research institute and NCI National Cancer Institute? | CRP (Cancer research program) |
| NAACCR annual review and certification of submitted data is certified based on: | Case ascertainment, completeness of data, DCO duplicate cases, passing edits timeliness |
| The data that is reportable for this standard setter is defied by Public Law 102-525: | CDC NPCR |
| Which of these states was part of the original SEER Program registries? 1973 | Connecticut Iowa New Mexico Utah Hawaii |
| The longest-standing and largest accreditation program is | CoC |
| The CoC accreditation site-vit process conducts discussions with the program's leadership to ensure understanding of: | how clinical care is provided, how accuracy of data collection is assured, how quality of care and patient outcomes are evaluated and improved |
| This Type of data motivates action at the community level and provides incentives for community involvement and ownership-: | Local level data |
| The US based independent nonprofit research organization created through the 2010 Affordable Care Act is | PCORI(patient centered outcome research institute) |
| The resource that is available to general public users and researchers to access the latest data on new cancer cases and deaths for the entire US is: | USCS data Visualization and USCS public use database |
| The cornerstone of all NAACCR initiatives that is essential to improving cancer surveillance nationwide is: | NAACCR Membership |
| As a collaborative effort to coordinate a change management process amount the the standard setting agencies, which of these subgroups were created: | HLSG and MLTG |
| This standard setter is an authoritative source of information on cancer incidence and survival in the United States: | SEER |
| Which standard setter was established in 1992 through the cancer Registries Amendment Act? | NPCR |
| The interval of time between when a patient, with a reportable diagnosis, has initial contact with the facility and the completion of the abstract is called | Abstracting time frame |
| The unique number assigned to the patient in the cancer registry database is the: | Accession number |
| This section of the abstract that contains override flags and identifies coding systems is: | case administration |
| The number assigned to each primary for the patient is the | sequence number |
| Who is responsible for ensuring that data collected in the abstract are complete, accurate and timely? | Cancer Registrar |
| What agencies set the standards for cancer registry data collection? | CDC/NPCR, NCI/SEER, ACoS/CoC |
| The ___ reflects the patient's diagnoses and treatments regardless of where it took place: | abstract |
| CoC's Rapid Cancer Reporting System(RCRS) is a system that: | allows national data to be available n a current manner, supports ongoing quality assurance programs, evaluates variations in care delivered to patients |
| The information in the initial abstract includes the data the patient was known to be alive or date of death, status of the cancer and is updated at least annually according to CoC-accreditation requirements, is part of which process? | Follow up |
| The central cancer registry relies on what information to help reconcile duplicate cases and confirm the accuracy of coded data items | text |
| A patient that has only one malignant primary tumor is assigned which sequence number | 00 |
| Treatment that is administered or planned at the time of initial diagnosis is called: | first course |
| Who is responsible for informing other departments that a particular case will be presented at the cancer conference for which they are to present? | Cancer registrar |
| Aggregated state and national level data may not be available for use until ___ after the year of diagnosis | Two years |
| The accession number is usually generated by the : | Cancer Registry software |
| Which portion of the abstract refers to selected population characteristics that are used in cancer research and by heal care providers for marketing purposes | Demographics |
| If a patient was given an accession number and it was determined not to have a reportable tumor, what happens to the accession number? | Deleted from the registry |
| The data item that identifies, confirms and supports the body organ or tissue where the tumor originated is called | Primary Site |
| This portion of the abstract that contains information on TNM categories is called: | Stage of Disease at Diagnosis |
| The data item that has increased in importance as quality of survival is studied more intensely is : | Date of First Recurrence |
| The data item that categorizes cases for analysis purposes and is used to indicate the type of interaction the patient had with the reporting facility is called: | Class of case |
| If a patient is diagnosed only one diagnosis of benign/borderline reportable tumor, the sequence number should be coded: | 60 |
| The number that identifies the patient and is used for all additional primaries the patient may develop regardless of the year in which the subsequent reportable tumors occur is called | The accession number |
| Most of the information to complete the patient identification data items is found in which portion of the medical record? | Admission registration form |
| This serves as an important resource for ensuring data collection is consistent in the registry? | Cancer registry policy and procedure manual |
| Which of the following ensure uniform data which allows for the comparing of data from different entities and systems? | Standard data definitions and collection rulses |
| To code the date of first recurrence the patient must have proven disease following a ________ first | Disease free interval |
| The section of the abstract that contains data items to describe the disease and include additional administrative information is called: | cancer identification |
| Guidelines of the abstract that contains data items to describe the disease and include additional administrative information is called | cancer identification |
| Guidelines for reporting text documentation is provided by | Central Cancer Registry |
| Where are clinical practice guidelines for oncology found | NCCN (National Cancer Comprehensive Network) |
| A registry is required to report its data to | Governing Agencies |
| The document that is used by cancer registries to ensure all reportable cancer cases are identified is called | Reportable list |
| The process of near real-time data submission is called | concurrent abstracting |
| On an annual basis, the central cancer registry conducts death clearance where there is a linkage between their database with the ______ file from their state's vital records department | Morality |
| Most cases are moved from suspense to the cancer registry based on | histology |
| Which of the following terms defines the occurrence of a separate independent diagnosis of cancer | case |
| Occasionally, cases may be missed for several different reasons, but it is important to determine | The cause and address it quickly |
| The central cancer registry plays a role in identifying cases that may have been missed by facilities through | death clearance |
| Once a problem with casefinding is identified or there is lower than expected case numbers, like the loss of a surgeon, it should be communicated to the cancer committee and the | Central Cancer Registry |
| The behavior codes that are never used by the hospital cancer registry are | /6/9 |
| Facilities that collect data requested by their cancer committee. These cases are known as | reportable by agreement cases |
| The data item based on the nature of the involvement of the facility in the care of the patient is called | Class of Case |
| When entering a case into the cancer registry suspense system a ____ ICD-O code based on review of the pathology report is included | Preliminary |
| Cases that are determined to be cancer through history are known as : | pathologically diagnoses |
| It is important for the cancer registry to know if which of the following departments are part of the hospital or privately owned | Radiation oncology departement |
| What type of cases are abstracted to meet central registry requirements ? | Non-analytic cases |
| Which of the following processes ensure all reportable cases are first identified and then reported to the central cancer registry | Casefinding |
| All potential cases identified from casefinding sources are entered into the: | suspense system |
| An independent survey at the facility level to identify possible issues with casefinding completeness is called | casefinding audit |
| A customized report generated from the HIM database to assist with casefinding is called | disease index |
| the type of casefinding that involves cancer registry staff retrieving and reviewing source documents is called | active |
| What is the effective date on which cancer registration began for the facility | Reference date |
| What type of medical codes indicate what occurred during a patient's hospital visits | Procedure |
| Most central cancer registries have a case of completeness goal of 95% of the ________ number of cases for both the central and hospital registries | expected |
| A historical analysis flags inconsistencies that can indicate the need to revise or update casefinding procedures and/or identify the need for training is performed through what process ? | Comparing annual caseloads to previous years |
| During casefinding most registrars actively review ___ pathology repot. | every |
| It is important to evaluate the usefulness of what types of casefinding sources and whether they identify cases not already found through other methods? | secondary sources |
| One of the most important uses of the disease index is to identify cases that are | clinically diagnosed |
| Complete casefinding requires registrars | be familiar with the relationship between ICD-O and ICD CM |
| The method of diagnosis is recorded in which of the following data items ? | Diagnostic confirmation |
| A reportable list is usually developed by the central registry, is composed of all the reportable case types collected by a cancer registry and clarifies the types of diagnoses that are not reportable | TRUE |
| The two most important casefinding sources for both the hospitals and central registries are | disease index and pathology reports |
| The planned use of the data and the reporting agencies to which the central registry reports determine the time frame for when casefinding abstracting and reporting must be done | TRUE |
| Death clearance is the process of | regional casefinding audits using the death certificates as a casefinding source |
| Tracking tools and status reports can help a registry to be sure that all casefinding sources have been thoroughly examined and in accordance with policy. | TRUE |
| Potentially reportable cases that have been identified and are waiting to be abstracted are stored in what is called the | Suspense system |
| Concurrent abstracting is | submitting data as near real-time as possible |
| Class of case defines | non analytic and analytic cases |
| The CoC survey focuses on which of the following activities except | how the budget is spent |
| The survey process is the same for every facility | FALSE it varies |
| Central registries periodically perform audits to determine case finding completeness | TRUE |
| What are some challenges to physician attendance at cancer conferences? | Ease of meeting room access administrative requirements conflicting schedules |
| Only CoC facilities hold cancer conferences | FALSE |
| The CoC sets standards to ensure that cancer care is delivered according to | Best evidence |
| the cancer research program | develops and implements evidence-based practices in surgical oncology, increase participation of community oncology surgeons in cancer research and cancer care activities, |
| The cancer research program cont | , reduces the impact of cancer by increasing knowledge and awareness of new evidence and practice standards, creates opportunities for meaningful health-services research |
| The NCDB(national cancer database) is jointly sponsored by the : | Acos acs |
Created by:
bridpar